Skip to main content
. 2020 Aug 18;2020:1428246. doi: 10.1155/2020/1428246

Table 3.

The changes in pain intensity from baseline to 12 and 24 weeks.

Outcomes Difference in mean change (95% CI) Between-group difference (95% CI)
WQXG GEG GEG vs. WQXG P
SF-MPQ (0–45)
 Week 12 −9.8 (−11.9 to −7.6) −7.9 (−10.4 to −5.3) −1.7 (−3.5 to 0.01) 0.051
 Week 24 −13.3 (−15.4 to −11.2) −11.4 (−13.9 to −8.9) −1.7 (−3.2 to −0.2)# 0.032

VAS (0–10)
 Week 12 −2.5 (−3.2 to −3.8) −1.9 (−2.8 to −1.0 −0.3 (−1.0 to 0.4) 0.357
 Week 24 −4.0 (−4.7 to −3.4) −2.8 (−3.8 to −1.9) −0.9 (−1.8 to −0.1)# 0.035

PPI (0–5)
 Week 12 −1.4 (−1.8 to −1.0) −1.2 (−1.7 to −0.7) −0.3 (−0.7 to 0.1) 0.166
 Week 24 −2.1 (−2.5 to −1.7) −1.6 (−2.1 to −1.1) −0.6 (−1.0 to −0.1)# 0.014

The pain intensity was assessed by SF-MPQ, and VAS and PPI as subtables were used for further evaluation. The changes in mean were calculated from the difference between the current value and the baseline data. Compared with baseline, P < 0.05; compared with the GEG at the same time point, #P < 0.05. CI, confidence interval; WQXG, Wuqinxi group; GEG: general exercise group; SF-MPQ: Short-Form McGill Pain Questionnaire; VAS: Visual Analog Scale; PPI: Present Pain Intensity.